ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 2 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 1,518 | -43.0% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 2,665 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | +33.3% | 2,665 | +136.5% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 1,127 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | -40.0% | 1,127 | -15.6% | 0.00% | – |
| Q3 2017 | $5,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | -16.7% | 1,335 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | +100.0% | 1,335 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 1,335 | -1.8% | 0.00% | – |
| Q4 2015 | $5,000 | – | 1,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
| Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
| WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
| Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
| BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
| Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |